TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2017

Cabazitaxel Versus Docetaxel As First-Line Therapy for Patients With Metastatic Castration-Resistant Prostate Cancer: A Randomized Phase III Trial-FIRSTANA.

Stéphane Oudard et al.PubMed ↗Publisher ↗

No numbers read from the abstract.